© 2022 MJH Life Sciences and Pharmacy Times – Pharmacy Practice News and Expert Insights. All rights reserved.
© 2022 MJH Life Sciences™ , Pharmacy Times – Pharmacy Practice News and Expert Insights. All rights reserved.
September 19, 2022
The most important thing you must do is listen to the patient, understand their concerns, and by doing that, you will gain their trust to be able to treat them appropriately.
Migraines are multifactorial and patient-specific, causing accessible care and treatments to be limited and ignored.
September 14, 2022
Experts review treatment options for first, second and recurring episodes of Clostridioides difficile infection.
A gastroenterologist reviews the long-term impact of dysbiosis and Clostridioides difficile infection.
September 12, 2022
Pharmacy Times spoke with Carina Dolan, PharmD, Editor in Chief of the Pharmacy Market Outlook, about the highlights and the big picture moving forward for hospitals and health systems.
Hawaii has a distinct culture, and the students said that has led them to have unique perspectives on culturally competent care.
September 09, 2022
About 1 in 8 women in the United States will develop breast cancer in their lifetime. Overall mortality for breast cancer has decreased over the years with the addition of complex treatment, such as PARP inhibitors. The webcast discusses this class of medications and see how they fit into the treatment paradigm for breast cancer.
September 07, 2022
Dr. Tom Lodise provides an overview of gut microbiota and the consequences of dysbiosis.
Dr. Abraham discusses importance of differential diagnosis of C. difficile infection (CDI) in patients with IBD and how both IBD and CDI should be managed.
The COVID-19 pandemic accelerated many changes in the pharmacy field, but maintaining that momentum and working together will be essential for the future growth of pharmacy.